Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy Controls

This study has been completed.
Sponsor:
Collaborator:
North Bristol NHS Trust
Information provided by:
University of Bristol
ClinicalTrials.gov Identifier:
NCT01162434
First received: July 13, 2010
Last updated: July 11, 2012
Last verified: August 2011
  Purpose

Treatment resistant depression (TRD) is a major health concern, with 10% of patients with major depressive disorder not responding to conventional treatments. The investigators propose to compare the MRI (magnetic resonance imaging) brain scans of patients with TRD, which were collected during surgical planning for deep brain stimulation, with age, sex, handedness and education-matched healthy volunteer controls, to investigate anatomical differences, specifically the volume of certain brain structures.


Condition
Mental Disorders

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Volumetric Brain MRI (Magnetic Resonance Imaging) Comparison of Patients With Treatment Resistant Depression (TRD) Undergoing Deep Brain Stimulation (DBS) With Age, Sex and Education Matched Healthy Controls

Resource links provided by NLM:


Further study details as provided by University of Bristol:

Primary Outcome Measures:
  • Region of interest analysis [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Comparison of RoI volumes of specific brain structures between patients with TRD undergoing deep brain stimulation (DBS) and healthy volunteers. Specific brain regions are: hippocampus, orbitofrontal cortex and subgenual cingulate, amygdala, dorsal anterior cingulate cortex, and dorsomedial prefrontal cortex.

  • Whole brain analysis [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Whole brain MRI volumetric comparison between TRD patients undergoing DBS and healthy volunteers.

  • Comparison of abnormalities [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Comparison of other potential abnormalities e.g. areas of hyperintensity in white matter in specific brain volumes between patients with TRD undergoing DBS and healthy volunteers.


Enrollment: 21
Study Start Date: February 2010
Study Completion Date: February 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Patients
Up to 8 patients who have received Deep Brain Stimulation for Treatment Resistant Depression at Frenchay Hospital (UK) will be recruited.
Healthy volunteers
Up to 16 healthy volunteers, matched to the DBS patients on age, sex, handedness, and education, will be recruited.

Detailed Description:

All the patients treated at Frenchay Hospital, UK, with deep brain stimulation (DBS) for treatment resistant depression (TRD) will be given a Patient Information Sheet, and asked if they would like to participate in this research related to their condition. If they indicate they would like to participate, patients will be asked to sign a separate informed consent form (ICF) to give permission for their previously collected MRI scan to be used for this new research purpose. Information on handedness of the patients has not been previously collected, so patients will be given a short questionnaire to determine their handedness. The patients will not be required to perform any further tasks.

For each patient that agrees to participate in the study, two healthy matched control participants will be recruited. Participants will be recruited from an existing volunteer database and by local advertisements.

Respondents interested in participating will be given a letter of invite and a participant information sheet. They will be asked several basic questions including contact details, health status, age, sex, handedness, highest qualification achieved, and scanning requirements in order to assess their basic suitability for the study. If suitable, participants will be invited to attend a screening visit. Here, the informed consent form will be signed, then their medical history will be taken, and they will be given a MINI neuropsychiatric evaluation to assess their physical and mental status. Females who have the possibility of being pregnant will be asked to provide a urine sample to check they are not pregnant, and will be required to use adequate contraception until after their scan.

If suitable, participants will complete two computerised tests of mood. Then they will have a scan date booked at Frenchay hospital. At the scanning visit, participants will be assessed for any changes in health since their screening visit, and then will complete an MRI scan. The same scanner with the same sequences will be used for the healthy controls that were used for the patients. Two sequences will be collected: a coronal T1 FFE (fast field echo) volume acquisition and an axial high resolution T2 limited volume acquisition where 16 slices are collected with 8 above the ACPC (anterior commissure posterior commissure) plane and 8 below. These sequences match the sequences that our DBS patients have had and will allow both automated anatomical quantitative analysis (using Statistical Parametric Mapping version 5 (SPM5)) and quantitative description of other MRI signals such as white matter bright spots. Participants will receive no payment, but can have a printout of their scan if they wish.

The scans will then be analysed and compared to the patient scans.

  Eligibility

Ages Eligible for Study:   26 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients who have received Deep Brain Stimulation (DBS) for Treatment Resistant Depression at Frenchay Hospital, UK., and healthy volunteers who are matched to the DBS patients, sampled from the local area.

Criteria

Inclusion Criteria:

  • Up to 12 females and 4 males, sex, handedness and age (±5 years) matched for the DBS patients.

Exclusion Criteria:

  • Current or past psychiatric disorder as assessed with MINI and clinical interview.
  • Significant head injury.
  • Standard MRI risk criteria (metallic clips or pins in body, pacemaker, aneurysm clips, pregnancy, possibility of metal in eyes including history of traumatic eye injury, shrapnel or bullet injuries).
  • Inability to lie in the scanner for whatever reason (e.g. claustrophobia).
  • Current acute medical illness.
  • Started on new medicines in the last two months that the investigator feels may interfere with the study.
  • Any medical condition that in the principle investigator's opinion is not matched in the DBS sample (e.g. epilepsy, diabetes, cardiac/hepatic/renal failure but not hypertension).
  • The investigator feels that the volunteer is unsuitable for the research protocol, or unable or unwilling to comply with study procedures.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01162434

Locations
United Kingdom
Bristol Royal Infirmary
Bristol, United Kingdom, BS2 8HW
Sponsors and Collaborators
University of Bristol
North Bristol NHS Trust
Investigators
Principal Investigator: Andrea Malizia, MD University of Bristol
  More Information

No publications provided

Responsible Party: Dr. Birgit Whitman, University of Bristol
ClinicalTrials.gov Identifier: NCT01162434     History of Changes
Other Study ID Numbers: UoB1112, 10/H0102/15
Study First Received: July 13, 2010
Last Updated: July 11, 2012
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by University of Bristol:
Treatment resistant depression
Deep brain stimulation
Brain volumetric analysis

Additional relevant MeSH terms:
Depression
Depressive Disorder
Depressive Disorder, Treatment-Resistant
Mental Disorders
Psychotic Disorders
Behavioral Symptoms
Mood Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on October 29, 2014